Hereditary Cancer Tests - Galaxi Genomics

Hereditary Cancer Genomics – Uncover Inherited Cancer Risk

At Galaxi Genomics, we provide comprehensive hereditary cancer testing to help oncologists identify patients with an inherited predisposition to cancer. Our advanced genomic panels detect germline mutations and assess polygenic risk, enabling early intervention, personalized screening, and targeted prevention strategies.

Hereditary Cancer Panel

Hereditary Cancer susceptibility testing for 13 hereditary cancer types – Enables analysis of SNVs, InDels, fusions, splice variants, and CNVs, including both copy number gains and losses across 500+ genes.

Genomic Instability and Therapeutic Biomarkers – DNA Repair & Targetable Biomarkers (HRD, HRR, GIM) and Immunotherapy Biomarkers (TMB, MSI).

Germline Mutation Detection

Identify pathogenic variants linked to hereditary breast, ovarian, colon, gastric, and other cancers.

Polygenic Risk Score (PRS) Analysis

Assess cumulative risk from multiple genetic markers for a more comprehensive risk evaluation.

Actionable Insights

Guide risk-reducing strategies, enhanced surveillance, and family testing recommendations.

Key Benefits for Oncologists & Patients

Comprehensive Gene Coverage

Includes high-risk genes (*BRCA1/2,
PALB2, ATM, CHEK2, MLH1, MSH2, MSH6, PMS2, APC, CDH1, PTEN, TP53*,
and more).

Flexible Precision Oncology Testing Suite

50-Gene Hotspot, 400-Gene Hereditary, and 500-Gene TMB/MSI Panels, Whole Genome and Whole Exome tests.

Personalized Prevention Plans

Supports early detection protocols,
prophylactic surgery decisions, and tailored screening.

Fast, Accurate Results

Streamlined reporting with clear clinical
interpretations.

Who Should Be Tested ?

Testing is recommended for patients with:

A personal or family history of early-onset cancers (e.g., breast cancer <50, multiple primary tumors).

Known hereditary cancer syndromes (e.g., Lynch syndrome, HBOC, Li- Fraumeni).

Uninformative genetic test results from limited panels.

Why Choose Our Hereditary Cancer Testing?

Evidence-Based

Analyzes well-established cancer susceptibility genes and emerging risk markers.

Clinically Actionable

Specific gene mutations, linked to clear management recommendations, including surgical interventions or specific medications.

Family Impact

Identifies at-risk relatives who may benefit from genetic counseling and testing.

Why Work With Galaxi Genomics?

Precision Genomics, Powered by Rigorous Science

At Galaxi Genomics, we combine cutting-edge NGS technology with advanced analytics to deliver clinically actionable genomic insights—helping physicians make confident, evidence-based treatment decisions.

ACMG-AMP Compliant Variant Classification

Strict adherence to clinical guidelines for consistent, reliable variant interpretation.

AI & Statistical Evidence-Driven Refinement

Enhance variant assessment with machine learning and population genomics for higher accuracy.

Actionable Reports for Clinicians

Clear, therapy-focused insights with evidence strength, drug associations, and clinical guidance.

Oncologist-Validated Solutions

Collaborate with oncologists to refine and validate genomic-based treatment strategies.

Fast, Impactful Results

Optimized workflows ensure rapid turnaround without compromising precision.

Comprehensive Evidence Backing

Leverage literature, global genomic databases, and population studies to reinforce test reliability.